Skip to main content
Log in

A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Haemoglobinopathies are the most common hereditary disorders in Greece. Although there is a successful national prevention program, established 35 years ago, there is lack of an official registry and collection of epidemiological data for haemoglobinopathies. This paper reports the results of the first National Registry for Haemoglobinopathies in Greece (NRHG), recently organized by the Greek Society of Haematology. NRHG records all patients affected by thalassaemia major (TM), thalassaemia intermedia (TI), "H" Haemoglobinopathy (HH) and sickle cell disease (SCD). Moreover, data about the annual rate of new affected births along with deaths, between 2000 and 2010, are reported. A total of 4,506 patients are registered all over the country while the number of affected newborns was significantly decreased during the last 3 years. Main causes for still having affected births are: (1) lack of medical care due to financial reasons or low educational level; (2) unawareness of time limitations for prenatal diagnosis (PD); due either to obstetricians’ malpractice or to delayed demand of medical care of couples at risk; and (3) religious, social or bioethical reasons. Cardiac and liver disorders consist main causes for deaths while life expectancy of patients lengthened after 2005 (p < 0.01). The NRHG of patients affected by haemoglobinopathies in Greece provides useful data about the haemoglobinopathies in the Greek population and confirms the efficacy of the National Thalassaemia Prevention Program on impressively decreasing the incidence of TM and sickle cell syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Schizas N, Tegos C, Voutsadakis A, Arabatzis G, Angelopoulou P, Chrysanthopoulos K, Athanasiadou A, Bathrelou S, Rombos J, Skarlos D, Davakis M (1977) The frequency and distribution of β-thalassaemia and abnormal hemoglobins in Greece. A study of 15.000 reruits. Hell Armed ForcesMed Rev 11(suppl 1):197–203

    Google Scholar 

  2. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V (1995) Prevention and control of haemoglobinopathies. Bull World Health Organ 73:375–386

    PubMed  CAS  Google Scholar 

  3. Cao A, Rosatelli C, Galanello R (1991) Population-based genetic screening. Curr Opin Genet Dev 1:48–53

    Article  PubMed  CAS  Google Scholar 

  4. Scalone L, Mantovani LG, Krol M, Rofail D, Ravera S, Bisconte MG, Borgna-Pignatti C, Borsellino Z, Cianciulli P, Gallisai D, Prossomariti L, Stefàno I, Cappellini MD (2008) Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassaemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin 24(7):1905–1917

    Article  PubMed  Google Scholar 

  5. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassaemia major patients with asymptomatic myocardial siderosis. Blood 107:3738–3744

    Article  PubMed  CAS  Google Scholar 

  6. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ (2005) Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 21:531–538

    Article  PubMed  Google Scholar 

  7. Chouliaras G, Berdoukas V, Ladis V, Kattamis A, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Karagiorga-Lagana M (2011) Impact of magnetic resonance imaging on cardiac mortality in thalassaemia major. J Magn Reson Imaging 34:565–569

    Article  Google Scholar 

  8. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42

    Article  PubMed  Google Scholar 

  9. Modell B, Khan M, Darlison M (2000) Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 355:2051–2052

    Article  PubMed  CAS  Google Scholar 

  10. Telfer P, Coen GP, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Simamonian K, Skordos G, Sitarou M, Angastiniotis M (2006) Survival of medically treated thalassaemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematol 91:1187–1192

    Google Scholar 

  11. Borgna-Pignati C, Rugolotto S, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassaemia major treated with transfusion and deferoxamine. Haematol 89:1187–1193

    Google Scholar 

  12. Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C (2005) Longitudinal study of survival and causes of death in patients with thalassaemia major in Greece. Ann N Y Acad Sci 1054:445–450

    Article  PubMed  Google Scholar 

  13. Charafeddine K, Isma'eel H, Charafeddine M, Inati A, Koussa S, Naja M, Taher A (2008) Survival and complications of beta-thalassaemia in Lebanon: a decade's experience of centralized care. Acta Haematol 120(2):112–116

    Article  PubMed  CAS  Google Scholar 

  14. Bazrgar M, Peiravian F, Abedpour F, Karimi M (2011) Causes for hospitalization and death in Iranian patients with β-thalassaemia major. Pediatr Hematol Oncol 28(2):134–139

    Article  PubMed  Google Scholar 

  15. Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana M (2011) Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol 86:332–338

    Article  PubMed  Google Scholar 

  16. Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E (2010) The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 115:2354–2363

    Article  PubMed  CAS  Google Scholar 

  17. Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, Ripalti M, Sodani P, Tomassoni S, Visani G, Lucarelli G (2002) Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassaemia following bone marrow transplantation. Blood 100(1):17–21

    Article  PubMed  CAS  Google Scholar 

  18. Borgna-Pignatti C (2007) Surviving with thalassaemia major: the Italian experience. Pediatr Hematol Oncol 24:75–78

    Article  PubMed  Google Scholar 

  19. Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, Renda D, Lai ME, Mandas A, Forni G, Piga A, Bisconte MG (2004) Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 124(1):114–117

    Article  PubMed  Google Scholar 

  20. Lovet JM, Burroughs A, Bruix J (2003) Hepatocellural carcinoma. Lancet 362:1907–1917

    Article  Google Scholar 

  21. Mancuso A, Sciarrino E, Renda MC, Maggio A (2006) A prospective study of hepatocellular carcinoma incidence in thalassaemia. Hemoglobin 30(1):119–124

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the patients, their families and the medical and nursing staff of the following centers: General Hospital of Athens "Laiko", Children’s University Hospital of Athens "Agia Sofia", University General Hospital of Thessaloniki AHEPA, University Hospital of Thessaloniki Ippokrateion, University Hospital of Patras, University Hospital Hippocration of Athens, University Hospital of Larissa, General Hospital "Achilopouleio" of Volos, "DRAKOPOULEIO" Blood Centre of Athens, University Hospital of Ioannina, Venizeleio Hospital of Heraklion, General Hospital of Corfu, General Hospital of Karditsa, General Hospital of Corinthos, "Karamandaneio" Children's Hospital, Children’s Hospital of Penteli, General Hospital of Rhodes, Children's Hospital "Pan. & Aglaia Kyriakou" of Athens, General Hospital "Agios Panteleimon" of Nikea, General Hospital of Chalkida, General Hospital "Agios Pavlos" of Thessaloniki, General Hospital of Chania, General Hospital of Kalamata, General Hospital Vostanion of Mytilini, General Hospital "G. Gennimatas" Athens, General Hospital of Xanthi, General Hospital of Trikala, General Hospital of Arta, General Hospital of Serres, Social Security Institute of Pireaus, General Hospital of Sparte, University Hospital of Alexandroupoli, University Hospital of Heraklio "PEPAGNI", General Hospital of Katerini, General Hospital of Kavala, General Hospital of Kozani "Mamatseio", Hospital "Chatzikostas" of Ioannina, General Hospital of Amaliada, General Hospital of Rethymno, General Hospital of Kos, General Hospital of Athens “Aretaieio”, General Hospital of Tripoli, Children’s Hospital of Athens "Agia Sofia". Furthermore, the authors want to especially thank Mrs. Maria Tsalkani for her effort to collect this large amount of data in a limited period of time.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Ersi Voskaridou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Voskaridou, E., Ladis, V., Kattamis, A. et al. A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births. Ann Hematol 91, 1451–1458 (2012). https://doi.org/10.1007/s00277-012-1465-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1465-7

Keywords

Navigation